ILTOO Pharma is pioneering the field of Tregs directed therapies for treating a large spectrum of auto-/neuroimmune and inflammatory diseases
ILTOO Pharma is focused on Amyotrophic lateral sclerosis, which is our priority indication
ILTOO Pharma built its leadership on strong and valuable academic and industrial partnerships
